ReviewRSC advances2025

Current progress of 1,2,3-triazole hybrids as EGFR inhibitors for cancer therapy - a literature review.

Hussam Elddin Nabeih Khasawneh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.